- Home
- Services
- Nanoparticle Functionalization Services
- Nanoparticle Surface Functionalization Services
- Fluorescent-Labeled Lipid Nanoparticles
Custom fluorescent surface labeling services for lipid nanoparticles, enabling precise carrier tracking, intracellular trafficking visualization, and targeted delivery validation across in vitro and in vivo research models.
Fluorescent-labeled LNPs are lipid nanoparticles with fluorophores on the surface or embedded in the lipid bilayer. Unlike unlabeled LNPs, they can be directly seen and tracked using fluorescence microscopy, flow cytometry, and live-animal imaging. Researchers use them to follow particle distribution, cellular uptake, and endosomal escape in real time. Fluorescent-labeled LNPs are ideal for cell uptake quantification, endosomal escape mechanism studies, organ distribution imaging, tumor targeting validation, surface ligand binding confirmation, and carrier stability monitoring.
BOC Sciences delivers fluorescent-labeled LNP development services covering dye selection, particle formulation, surface modification strategies, physicochemical validation, and imaging-readiness confirmation. Our integrated functionalization capabilities combine surface fluorescence engineering with core LNP platforms, supporting therapeutic delivery, mechanistic research, and diagnostic imaging applications.
Fluorescent Labeled Lipid Nanoparticle Structure DiagramBOC Sciences supports the full workflow from fluorescent dye selection and surface incorporation to physicochemical characterization and imaging validation, ensuring that surface labeling serves as a reliable carrier-tracking tool.
We select and embed lipophilic fluorophores into the LNP lipid bilayer based on your imaging platform, wavelength requirements, and biological model compatibility.
We introduce fluorophores onto LNP surfaces through multiple technical pathways matched to particle composition, dye photophysical properties, and stability requirements—balancing labeling efficiency with particle integrity.
We rigorously characterize fluorescent-labeled LNPs to confirm that surface modification has not compromised particle quality, and we quantify labeling efficiency with analytical precision.
We validate that fluorescent surface labeling translates into reliable, interpretable imaging data across cellular and tissue-level models.
BOC Sciences supports diverse fluorescent dye chemistries and surface incorporation technologies for nanoparticle functionalization, enabling researchers to select the optimal labeling strategy based on imaging modality, spectral requirements, and functional constraints.
We offer a comprehensive spectrum of fluorophores compatible with LNP lipid bilayers and surface chemistries, spanning from visible to near-infrared wavelengths for multiplexed and deep-tissue imaging.
| Dye / Conjugate | Structural Features | Excitation / Emission | Typical Applications |
|---|---|---|---|
| DiD (DiIC18(5)) | Long-chain dialkylcarbocyanine; lipophilic tail inserts into lipid bilayer; far-red emission. | 644 / 665 nm | Deep-tissue in vivo imaging; flow cytometry; membrane tracking with low autofluorescence background. |
| DiR (DiIC18(7)) | Near-infrared dialkylcarbocyanine; extended conjugation for NIR-I window penetration. | 748 / 780 nm | Whole-animal IVIS imaging; tumor accumulation studies; BBB penetration assessment. |
| DiO / DiI | Green and orange carbocyanines; standard lipophilic membrane dyes for in vitro microscopy. | 484 / 501 nm; 549 / 565 nm | Confocal co-localization; high-content screening; dual-color membrane tracking. |
| Bodipy-FL / TR | Boron-dipyrromethene core; high quantum yield; narrow emission bandwidth; photostable. | 505 / 511 nm; 589 / 616 nm | Super-resolution microscopy; FRET donor/acceptor pairs; photostability-critical tracking. |
| NBD-PE / NBD-PS | Nitrobenzoxadiazole-labeled phospholipids; integrates as structural membrane component. | 460 / 534 nm | Membrane fusion assays; lipid mixing studies; bilayer integrity monitoring. |
| Cy5-PEG-DSPE / Cy7-PEG-DSPE | Cyanine dyes linked to PEG-DSPE for post-insertion; hydrophilic PEG spacer positions dye outward. | 649 / 670 nm; 743 / 767 nm | Post-insertion surface labeling; controlled density; compatible with microfluidic workflows. |
We develop fluorescent labeling methods according to LNP composition, dye photophysical properties, desired surface density, and stability requirements. Each method offers distinct trade-offs between labeling efficiency, particle integrity preservation, and spectral flexibility.
| Labeling Strategy | Service Subtype | Chemical / Physical Principle | Suitable Use Cases |
|---|---|---|---|
| Physical Membrane Embedding | Lipophilic dye co-assembly | DiD, DiR, or DiO dissolved in organic lipid phase partitions into bilayer during ethanol-dilution or microfluidic self-assembly. | Highest membrane integration stability; lowest post-labeling processing; ideal for hydrophobic dye incorporation. |
| Fluorescent phospholipid integration | NBD-PE or rhodamine-PE replaces non-fluorescent phospholipid mole-for-mole in bilayer, acting as structural component. | Mechanistic studies requiring minimal membrane perturbation; quantitative lipid-mixing assays. | |
| Post-Insertion | Fluorescent PEG-lipid micelle insertion | Pre-formed micelles of Cy5-PEG-DSPE insert into LNP outer leaflet via hydrophobic DSPE anchor; PEG projects dye into aqueous phase. | Late-stage labeling of sensitive payloads; precise density control; minimal disruption to core formulation. |
| Cholesterol-fluorophore insertion | Fluorophore-cholesterol conjugates insert into bilayer via cholesterol anchor; shorter spacer reduces PEG shielding effects. | Maximal surface exposure for receptor accessibility; applications where dye must project beyond PEG corona. | |
| Covalent Surface Coupling | Thiol-maleimide coupling | Thiol-functionalized fluorophores react with Mal-PEG-lipid on LNP surface; high chemoselectivity under mild pH. | Irreversible attachment; precise stoichiometric control; applications requiring stable dye retention in serum. |
| DBCO-azide click chemistry | Azide-functionalized fluorophores react with DBCO-PEG-lipid via SPAAC; no copper catalyst required. | Bioorthogonal labeling of sensitive biological surfaces; compatible with protein-loaded LNPs. | |
| EDC/NHS amide coupling | Carboxyl-functionalized LNP surfaces activated with EDC/NHS react with amine-fluorophores to form stable amide bonds. | Classical robust coupling; high reaction efficiency for small-molecule fluorophores; cost-effective scale-up. | |
| Ligand Pre-Labeling | Fluorophore conjugation to antibody, peptide, or aptamer before LNP surface attachment | Dye is positioned on the outermost targeting layer, enabling direct visualization of ligand-receptor engagement and dissociation kinetics. | Targeted LNP validation; proof-of-concept ligand screening; modular ligand exchange platforms. |
Develop surface-fluorescent lipid nanoparticles with optimized dye stability, spectral clarity, particle integrity, and imaging compatibility for mechanistic delivery research.
Surface fluorescent labeling transforms LNPs from opaque delivery vehicles into traceable systems whose carrier fate, intracellular routing, and targeting behavior can be directly visualized and quantified across experimental scales.
Carrier-Tracking Integrity
By marking the lipid membrane rather than the payload, fluorescent surface labeling reports the true fate of the nanoparticle itself. This eliminates the ambiguity inherent in payload-only tracking, where leaked or degraded cargo can be mistaken for intact carrier delivery. Researchers can confidently distinguish between intact LNP accumulation, membrane rupture events, and free-dye diffusion—foundational clarity for any mechanistic delivery study.
Cell Uptake & Trafficking Studies
Fluorescent labeling enables real-time visualization of LNP internalization. Flow cytometry quantifies uptake rates and mean fluorescence intensity, while confocal microscopy tracks subcellular routing to distinguish clathrin-mediated, caveolae-mediated, and macropinocytic entry pathways. Co-localization with endosomal markers validates endosomal escape efficiency.
Surface Ligand Validation
Fluorophores on targeting ligands—antibodies, peptides, or aptamers—reveal whether ligands are displayed on the LNP surface, bind stably to receptors, and co-internalize with the particle. Dual-channel imaging against membrane dyes distinguishes ligand retention from dissociation, enabling accurate assessment of targeting specificity.
Quantitative Correlation
Each fluorescent LNP batch is delivered with a complete correlation dataset linking fluorescence intensity to particle concentration, mean diameter, PDI, and surface charge. This quantitative framework enables researchers to convert raw imaging signals into physiologically meaningful metrics—such as particles per cell or tissue concentration—rather than arbitrary fluorescence units.
BOC Sciences applies surface fluorescent labeling across diverse LNP formulations and payload types, matching the labeling strategy to the core particle architecture and intended imaging application.
| Service Subtypes by Payload | Application Overview | Request Information |
|---|---|---|
| Fluorescent-Labeled LNP Development for siRNA | For gene silencing mechanism studies. Track carrier fate via membrane labeling while correlating siRNA uptake with target gene knockdown efficiency, supporting uptake pathway screening and endosomal escape optimization. | Inquiry |
| Fluorescent-Labeled LNP Development for mRNA | For therapeutic protein expression studies. Distinguish membrane-positive cells from protein-expressing cells, supporting transfection efficiency quantification, translation kinetics analysis, and live tissue distribution imaging. | Inquiry |
| Fluorescent-Labeled LNP Development for Protein/Peptide | For protein antigen or therapeutic peptide delivery research. Provide carrier visualization for non-fluorescent payloads, supporting cellular uptake quantification, intracellular trafficking tracking, and targeted tissue accumulation analysis. | Inquiry |
| Fluorescent-Labeled LNP Development for Small Molecule | For targeted delivery of hydrophobic chemotherapeutics or diagnostic molecules. Simultaneously track carrier distribution and drug release behavior, supporting tumor accumulation quantification, pharmacokinetic analysis, and efficacy correlation assessment. | Inquiry |
| Fluorescent-Labeled LNP Development for Targeted Delivery | For targeted ligand validation and receptor-mediated delivery studies. Directly observe surface antibody, peptide, or aptamer binding and internalization processes, supporting targeting specificity confirmation and in vivo distribution imaging. | Inquiry |
| Fluorescent-Labeled LNP Development for Co-Delivery | For multi-drug combination delivery research. Simultaneously track encapsulation status and coordinated release of multiple payloads through independent spectral channels, supporting synergistic dosing mechanism analysis and combination therapy optimization. | Inquiry |
Surface fluorescent labeling introduces distinct technical hurdles—dye leakage, quenching, functional interference, and signal ambiguity—that must be systematically addressed to generate reliable imaging data. BOC Sciences solves these challenges through physicochemical design and rigorous validation.
✔ Fluorescent Dye Leakage from the Lipid Membrane
Lipophilic dyes can desorb from the bilayer upon dilution, protein binding, or lipoprotein exchange in serum, causing false-positive signals from free dye. We solve this by screening dye-lipid affinity pairs, optimizing cholesterol content to tighten membrane packing, and selecting anchor-stabilized fluorescent lipids (e.g., NBD-PE) that resist exchange. Each formulation undergoes serum stability testing with quantitative leakage thresholds to ensure signal fidelity.
✔ Particle Aggregation or Size Increase After Labeling
Introduction of hydrophobic dyes or bulky fluorescent conjugates can increase surface hydrophobicity and induce inter-particle aggregation. We rebalance helper lipid, cholesterol, and PEG-lipid ratios to restore colloidal uniformity, typically achieving mean diameter<150 nm with PDI <0.20 even after high-density fluorescent modification. For lipid nanoparticle encapsulation projects, we verify that surface engineering does not compromise core payload retention.
✔ Fluorescence Quenching from Surface Crowding
High local dye density on the LNP surface promotes H-aggregate formation and fluorescence self-quenching, reducing signal-to-noise ratio. We mitigate this through density-gradient dilution (optimizing dye-to-lipid molar ratios), PEG spacer length modulation (PEG2000 vs. PEG5000), and dye library screening to identify fluorophores with low aggregation propensity in lipid bilayers, preserving high quantum yield at functional labeling densities.
✔ Masking of Targeting Ligands by Fluorescent Corona
Dense fluorescent PEG layers can sterically shield underlying targeting antibodies or peptides from receptor access. We implement layered surface architectures—positioning the fluorophore on shorter PEG tethers while extending targeting ligands on longer PEG spacers, or using cholesterol-anchored dyes that sit deeper in the membrane—to ensure that receptor binding avidity remains fully accessible while fluorescence reporting is maintained.
✔ Inability to Distinguish Free Dye from LNP-Bound Dye
Unbound fluorescent impurities or leaked dye create background noise that obscures true particle signals. We enforce rigorous post-labeling purification via size-exclusion chromatography (SEC) or sucrose density gradients to remove free dye micelles. Each batch is validated with a dye-retention index—quantifying the percentage of total fluorescence remaining particle-associated after 24-hour serum incubation—to guarantee that imaging data reflects intact LNP distribution.
✔ Loss of Encapsulation Efficiency During Surface Modification
Post-insertion or covalent coupling conditions can disrupt the delicate ionic equilibria required for high-efficiency nucleic acid encapsulation. We optimize aqueous phase pH, ionizable lipid composition, and mixing kinetics to maintain >85% encapsulation efficiency for siRNA and mRNA payloads during and after fluorescent surface modification. For nucleic acid encapsulation, we validate retention by RiboGreen and gel electrophoresis before and after surface engineering.
BOC Sciences helps research teams design fluorescent surface labeling strategies that distinguish intact particles from free dye, preserve payload function, and deliver quantitative imaging data.
We begin by discussing your imaging platform (confocal, flow cytometry, IVIS, high-content screening), target biological model (cell lines, 3D spheroids, xenografts), spectral requirements (single vs. multi-channel), and the fundamental question your experiment must answer: Do you need to track the intact carrier, visualize surface ligand binding, or monitor membrane integrity during endosomal escape? Based on these inputs, BOC Sciences prepares a tailored fluorescent labeling plan with dye selection rationale, density targets, and analytical milestones.
We design a labeling strategy matched to your LNP architecture and functional constraints. The design encompasses dye selection (lipophilic membrane dye vs. fluorescent PEG-lipid vs. covalent fluorophore), incorporation method (co-assembly vs. post-insertion vs. surface coupling), surface density planning (low 1–5 mol% for stealth, high >10 mol% for bright imaging), and compatibility assessment with existing targeting ligands or PEG shields. For multi-color projects, we design spectral panels with minimal bleed-through and FRET interference.
BOC Sciences prepares fluorescent-labeled LNP candidates using selected methods. During LNP process optimization, we systematically adjust dye concentration, lipid composition, PEG-lipid type, mixing parameters, and buffer exchange protocols. Matched unlabeled LNP controls are prepared in parallel. Each candidate is screened for particle size, PDI, zeta potential, encapsulation efficiency, and fluorescence intensity to identify the optimal labeling condition that maximizes signal while preserving particle quality.
Each fluorescent-LNP candidate undergoes comprehensive physicochemical and functional validation. We deliver particle size, PDI, zeta potential, encapsulation efficiency, fluorescence spectrum, quantum yield, and dye-retention kinetics. Functional evaluation includes nanoparticle in vitro evaluation—cellular uptake quantification, intracellular co-localization with organelle trackers, and membrane integrity assessment. For projects requiring in vivo data, we support preliminary biodistribution imaging and tissue accumulation analysis in appropriate research models.
Fluorescent surface-labeled LNPs enable direct visualization of carrier behavior across scales—from single-cell uptake events to whole-organism distribution—supporting mechanistic discovery and formulation optimization in nanomedicine research.
Challenge: A research team needed to track siRNA-LNP accumulation in A549 lung cancer xenografts over 48 hours. Their initial approach used Cy5-labeled siRNA as the sole fluorescent reporter. However, in vivo imaging showed rapid signal dispersion throughout the tumor and surrounding tissue, making it impossible to distinguish intact LNP accumulation from siRNA degradation products or free dye leakage. The team lacked a carrier-specific tracking channel.
Diagnosis: BOC Sciences identified that Cy5-siRNA alone could not report LNP integrity. Nucleic acid degradation and dye leakage in the tumor microenvironment produced diffuse background fluorescence that obscured true particle distribution. A membrane-bound near-infrared dye was required to track the intact lipid carrier independently of payload fate.
Solution: We engineered a dual-label system: DiR was embedded into the lipid bilayer during microfluidic co-assembly (0.8 mol% relative to total lipids), while Cy5 remained on the siRNA payload. We screened three DiR densities (0.5, 0.8, and 1.5 mol%) and evaluated particle size, PDI, siRNA encapsulation efficiency, and serum dye retention. The 0.8 mol% formulation achieved optimal brightness without self-quenching or size increase.
Result: The optimized DiR-labeled LNP maintained a mean diameter of 102 nm (PDI 0.14) and >88% siRNA encapsulation. In vivo IVIS imaging revealed distinct DiR signal accumulation in tumor tissue peaking at 24 hours, while Cy5 signal showed broader dispersion. Co-localization analysis indicated that approximately 60% of Cy5 signal remained DiR-associated at 24 hours, providing a quantitative metric for payload retention. The team obtained a clear carrier-tracking channel for their pharmacokinetic study.
Challenge: A biotechnology startup developed an aptamer-targeted LNP for prostate cancer delivery but could not verify whether the aptamer was successfully displayed on the particle surface or whether it mediated receptor-dependent uptake. Without direct ligand visualization, they could not distinguish aptamer-driven targeting from non-specific nanoparticle internalization.
Diagnosis: BOC Sciences determined that the aptamer lacked a reporter moiety and that the LNP carried no surface marker. The team needed a fluorescent aptamer conjugate and a spectrally distinct membrane tracker to simultaneously visualize ligand presentation and particle uptake, plus rigorous controls to prove receptor specificity.
Solution: We synthesized a Cy5-conjugated aptamer via amine-NHS chemistry and attached it to maleimide-PEG-DSPE-functionalized LNPs through thiol-maleimide coupling. The LNP membrane was independently labeled with DiO during co-assembly. We prepared three control groups: (1) Cy5-aptamer-LNP with DiO membrane; (2) scrambled-sequence Cy5-LNP; (3) receptor-blocked competition group. Uptake was evaluated by flow cytometry and confocal microscopy in PSMA-positive LNCaP cells.
Result: Confocal imaging showed >90% co-localization between Cy5 and DiO signals, confirming stable aptamer surface display. The Cy5-aptamer-LNP achieved a 4.2-fold higher uptake ratio in LNCaP cells compared to scrambled controls, and free aptamer competition reduced uptake by 78%. The client obtained definitive proof-of-concept data that their aptamer mediated specific, receptor-dependent targeting, enabling progression to in vivo efficacy studies.
Specialized Fluorescent Labeling ExpertiseOur scientists possess deep knowledge of dye photophysics, lipid bilayer chemistry, and surface conjugation methodologies. We understand how fluorophore selection, density, and placement affect both signal quality and particle function, ensuring that every labeling decision is grounded in mechanistic rationale.
Comprehensive Dye & Lipid InventoryWe stock an extensive library of lipophilic membrane dyes, fluorescent PEG-lipids, and reactive fluorophores spanning visible to near-infrared wavelengths. This breadth enables rapid parallel screening without material procurement delays, accelerating project timelines from weeks to days.
Integrated Imaging & Analysis PlatformsOur facilities feature fluorescence spectrometers, DLS/zeta analyzers with fluorescence detection, flow cytometry, confocal microscopy, and IVIS small-animal imaging—supporting the complete fluorescent-LNP workflow from formulation to imaging validation in one integrated environment.
Functional-First Labeling PhilosophyWe treat fluorescence as a passive reporter, never an active perturbant. Every labeling strategy is validated against unlabeled controls for particle size, PDI, encapsulation efficiency, and biological function, ensuring that imaging data reflects the behavior of the true therapeutic formulation.
Rapid Parallel ScreeningWe simultaneously screen multiple dye types, surface densities, and incorporation methods in 96-well microfluidic formats. This parallel approach identifies optimal labeling conditions faster than sequential iteration, helping you reach imaging-ready candidates with minimal delay.
Fluorescent-Labeled LNP development is mainly used to track the behavior of lipid nanoparticles themselves during formulation screening, cellular uptake studies, intracellular localization analysis, and biodistribution trend evaluation. In this service context, the fluorescent label is displayed on the LNP surface rather than encapsulated inside the particle core, so the signal reflects the particle shell or surface-associated lipid layer. This design helps researchers compare how different lipid compositions, PEG-lipid ratios, surface charges, ligand densities, or particle sizes influence LNP interaction with cells and tissues. It is especially useful when teams need to understand whether a formulation change improves nanoparticle access, uptake efficiency, or localization before connecting these findings with payload activity.
Surface labeling is selected when researchers want to follow the nanoparticle carrier rather than the internal payload. For Fluorescent-Labeled LNP systems, surface-attached dyes can help distinguish particle uptake from payload release, payload degradation, or reporter expression. This is important because a strong payload signal does not always mean efficient particle uptake, and strong particle uptake does not always lead to functional delivery. Surface fluorescence allows teams to evaluate membrane binding, endocytosis, intracellular trafficking, and formulation-dependent distribution patterns more directly. It also supports side-by-side comparison of targeted and non-targeted LNPs, helping researchers determine whether surface engineering truly changes nanoparticle behavior.
Fluorescent-Labeled LNP studies may use different dyes depending on the detection platform, wavelength channel, background signal, and study model. Common options include FITC, NBD, rhodamine, Cy3, Cy5, Cy7, DiO, DiI, DiD, and DiR. FITC and NBD are useful for basic fluorescence microscopy or flow cytometry, while rhodamine and Cy3 are often suitable for orange-red channel imaging. Cy5 and DiD are frequently chosen for far-red cellular uptake and colocalization studies because they can reduce interference from cellular autofluorescence. Cy7 and DiR are often considered for near-infrared imaging and tissue distribution trend studies. Dye selection should consider photostability, hydrophobicity, lipid anchoring, signal intensity, and compatibility with other fluorescent markers.
Fluorescent-Labeled LNP surface stability is evaluated by combining physicochemical characterization, dye-retention analysis, and biological control experiments. After labeling, the formulation is usually assessed for particle size, PDI, zeta potential, fluorescence intensity, dye-to-lipid ratio, and signal consistency after buffer exchange or storage-related stress. Free dye removal is critical because unbound dye can generate misleading background signals or transfer to cell membranes. Suitable controls may include unlabeled LNPs, free dye, dye-lipid micelles, and matched labeled LNPs. In cell-based studies, flow cytometry and confocal imaging can be used together to assess whether the fluorescent signal remains associated with nanoparticle uptake rather than nonspecific dye adsorption.
BOC Sciences supports Fluorescent-Labeled LNP development from surface-labeling strategy design to formulation preparation, characterization, and application-oriented evaluation. Based on the client’s payload type, cell model, imaging platform, and research goal, we help select suitable fluorescent lipids or dye-lipid conjugates, optimize labeling density, compare co-assembly and post-insertion approaches, remove free dye, and evaluate particle quality after modification. We can also design matched control LNPs and dual-readout systems to help distinguish particle uptake from payload function. For in vitro studies, we support uptake and localization analysis, while for in vivo research models, we can assist with distribution trend evaluation and formulation comparison.